BioCentury
ARTICLE | Company News

Cadila Pharmaceuticals, NovaSaid deal

January 20, 2014 8:00 AM UTC

NovaSaid and Cadila partnered to develop NovaSaid's therapeutic candidates for inflammation and pain, including rheumatoid arthritis (RA). The companies will collaborate on preclinical and clinical te...